The global contrast media/contrast agent market is anticipated to grow at a CAGR of around 5% during the forecast period. The rising FDA approvals are expected to drive the market during the forecast period. Several market players are actively participating in the R&D of contrast agents to get FDA approvals.
For instance, Bracco Imaging SpA had received FDA approval in December 2020 for ProHance, an MRI contrast agent which now can be used in neonates and pediatric patients under two years of age. Similarly, Bayer AG had received FDA approval in July 2019 for Gadavist, a gadolinium-based contrast agent which is used for the diagnosis of coronary artery diseases through cardiac MRI.
To Request a Sample of our Report on Contrast Media/Contrast Agent Market: https://www.omrglobal.com/request-sample/contrast-media-Contrast-agent-market
Market Coverage
- The market number available for – 2021-2029
- Base year- 2021
- Forecast period- 2023-2029
- Segment Covered-
- By Type
- By Procedure
- By Indication
- Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Competitive Landscape-Bayer AG, Bracco Imaging SPA, GE Healthcare, Lantheus Medical Imaging, Inc.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Contrast Media/Contrast Agent Market Report Segment
By Type
- Iodinated Contrast Media
- Gadolinium-based Contrast Media
- Microbubble Contrast Media
- Barium-based Contrast Media
By Procedure
- X-ray/Computed Tomography (CT)
- Magnetic Resonance Imaging (MRI)
- Ultrasound
By Indication
- Cardiovascular Disorders
- Oncology
- Gastrointestinal Disorders
- Neurological Disorders
- Other Indications
A full Report of Contrast Media/Contrast Agent Market is Available at: https://www.omrglobal.com/industry-reports/contrast-media-Contrast-agent-market
Contrast Media/Contrast Agent Market Report Segment by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Company Profiles
- Acro Lifesciences (I) Pvt. Ltd.
- Beijing Beilu Pharmaceutical Co., Ltd.
- Congruent Pharmachem Pvt. Ltd.
- iMax Diagnostic Imaging Ltd.
- B. Chemicals and Pharmaceuticals Ltd.
- Livealth Biopharma Pvt. Ltd.
- Nano Therapeutics Pvt. Ltd.
- Novalek Pharmaceuticals Pvt. Ltd.
- Onko Ýlaç San. ve Tic. A.Þ.
- Rege Imaging & Cine Films Pvt. Ltd.
- SANOCHEMIA Pharmazeutika GmbH
- Spago Nanomedical AB
- Subhra Pharma Pvt. Ltd.
- Taejoon Pharm
- Trivitron Healthcare Pvt. Ltd.
- Unijules Life Sciences
- Unispire Biopharma Pvt. Ltd.
- YZJ Group
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
